medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2002, Number 2

<< Back Next >>

Ann Hepatol 2002; 1 (2)

From blood to bile: recent advances in hepatobiliary transport

Arrese M, Accatino L

Language: English
References: 52
Page: 64-71
PDF size: 283.57 Kb.


Text Extraction

Transport of endogenous and exogenous substances from blood to bile is an essential function of the liver. In the last decade a still growing number of specific transport proteins present at the sinusoidal and canalicular membrane domains of hepatocytes and cholangiocytes have been cloned and functionally characterized. Studies assessing the molecular expression and function of these hepatobiliary transport proteins under different experimental conditions has helped to define the adaptive responses of hepatocytes to certain physiological states and to cholestatic liver injury and to a better understanding of the physiology of bile formation and of the pathophysiology of certain cholestatic diseases. Particularly relevant is the elucidation of the molecular bases of several forms of inherited cholestatic liver disease, which may help to the development of better diagnostic tools or to the design of new therapeutic strategies. In the present review we summarize recent experimental and clinical data involving hepatobiliary transport mechanisms.


REFERENCES

  1. Jansen PL. Foreword: from classic bile physiology to cloned transporters. Semin Liver Dis 2000; 20: 245-50.

  2. Erlinger S. Bile flow. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA. (eds.) The Liver: Biology and Pathobiology. Third ed. New York: © Raven Press Ltd., 1994; 769-788.

  3. Suchy FJ. Hepatocellular transport of bile acids. Sem Liv Dis 1993; 13: 235.

  4. Arrese M, Ananthananarayanan M, Suchy FJ. Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 1998; 44: 141-7.

  5. Strazzabosco M. New insights in cholangiocyte physiology. J Hepatol 1997; 27: 945-952.

  6. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol [Gastrointest Liver Physiol] 1998; 274: G157-69.

  7. Walters HC, Craddock AL, Fusegawa H, Willingham MC, Dawson PA. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am J Physiol [Gastrointest Liver Physiol] 2000; 279: G1188-200.

  8. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002; 64: 635-61.

  9. Suzuki H, Sugiyama Y. Transporters for bile acids and organic anions. Pharm Biotechnol 1999; 12: 387-439.

  10. Sun AQ, Arrese MA, Zeng L, Swaby I, Zhou MM, Suchy FJ. The rat liver Na+/Bile acid Cotransporter (Ntcp): Importance of the cytoplasmic tail to function and plasma membrane targeting. J Biol Chem 2000 (in press).

  11. Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin Liver Dis 2000; 20(3): 273-92.

  12. Cattori V, van Montfoort JE, Stieger B, Landmann L, Meijer DK, Winterhalter KH, Meier PJ, et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch 2001; 443(2): 188-95.

  13. Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, Gabazza EC, et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol 2000; 35: 659-64.

  14. Gründenmann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-552.

  15. Meijer DK, Smit JW, Hooiveld GJ, van Montfoort JE, Jansen PL, Muller M. The molecular basis for hepatobiliary transport of organic cations and organic anions. Pharm Biotechnol 1999; 12: 89-157.

  16. Trigatti BL, Rigotti A, Braun A Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochim Biophys Acta 2000; 1529: 276-286.

  17. Agellon LB, Torchia EC. Intracellular transport of bile acids. Biochim Biophys Acta 2000; 1486: 198-209.

  18. Cohen DE Hepatocellular transport and secretion of biliary lipids. Curr Opin Lipidol 1999; 10: 295-302.

  19. Hooiveld GJ, van Montfoort JE, Meijer DK, Muller M. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport. Eur J Pharm Sci 2000; 12: 13-30.

  20. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273: 10046-50.

  21. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-8.

  22. Wang R, Salem M , Yousef IM, Tuchweber B, LamP, Childs SJ, Helgason CD, et al. Targeted inactivation of Sister of P-glycoprotein gene (spgp) in mice results in non-progressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A 2001 (in press).

  23. Konig J, Nies AT, Cui Y, Leier I, Keppler D Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377-94.

  24. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271: 1126-8.

  25. Wielandt AM, Vollrath V, Manzano M, Miranda S, Accatino L, Chianale J. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. Biochem J 1999; 341: 105-11.

  26. Konig J, Rost D, Cui Y, Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999; 29: 1156-63.

  27. Keppler D, Konig J. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 2000; 20(3): 265-72.

  28. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92(16): 1295-302.

  29. Puglielli L, Amigo L, Arrese M, Nunez L, Rigotti A, Garrido J, Gonzalez S, et al. Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. Gastroenterology 1994; 107: 244-54.

  30. Oude Elferink RP, Groen AK Mechanisms of biliary lipid secretion and their role in lipid homeostasis. Semin Liver Dis 2000; 20: 293-305.

  31. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, Mol CA, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.

  32. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 1771-5.

  33. Koepsell H Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 1998; 60: 243-66.

  34. Borst P, Schinkel AH. Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet 1997; 13: 217-22.

  35. Roberts SK, Ludwig J, Larusso NF. The pathobiology of biliary epithelia. Gastroenterology 1997; 112: 269-79.

  36. Masyuk AI, Marinelli RA, LaRusso NF. Water transport by epithelia of the digestive tract. Gastroenterology 2002; 122(2): 545-62.

  37. Lee J, Boyer JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 2000; 20: 373-84.

  38. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998; 101: 2092-100.

  39. Trauner, M., Arrese, M., Soroka. C.J. , Ananthanarayanan, M., Koeppel, T.A., Schlosser, S.F, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and extrahepatic cholestasis. Gastroenterology 1997; 130: 255-264.

  40. Bowers BA, Branum GD, Rotolo FS, Watters CR, Meyers WC. Bile flow - An index of ischemic injury. J Surg Res 1987; 42: 565-569.

  41. Sumimoto K, Inagaki K, Yamada K, Kawasaki T, Dohi K. Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Transplantation 1988; 46: 506-509.

  42. Cutrin JC, Cantino D, Biasi F, Chiarpotto E, Salizzoni M, Andorno E, Masano G, et al. Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology 1996; 24: 1053-1057.

  43. Lemasters JJ, Thurman RG. The many facets of reperfusion injury. Gastroenterology 1995; 108: 1317-1320.

  44. Marra F. Ischemia-reperfusion: The liver under stress. Hepatology 1997; 25: 1276-1278.

  45. Arrese M, Karpen SJ. New horizons in the regulation of bile acid and lipid homeostasis: critical role of the nuclear receptor FXR as an intracellular bile acid sensor. Gut 2001; 49(4): 465-6.

  46. Jansen PLM, Müller M. The molecular genetics of familial intrahepatic cholestasis. Gut 2000; 47: 1-5.

  47. van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001; 21(4): 535-44.

  48. Thompson R, Strautnieks S. BSEP: function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001; 21(4): 545-50.

  49. de Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, Deleuze JF, Desrochers M, Burdelski M, Bernard O, Oude Elferink RP, Hadchouel M. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998; 95: 282-7.

  50. Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, Scheffer GL, Paul M, Burdelski M, Bosma PJ, Bernard O, Hadchouel M, Elferink RP. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120(6): 1448-58.

  51. Medina JF, Martinez-Anso, Vázquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997; 25: 12-7.

  52. Brockmoller J, Cascorbi I, Henning S, Meisel C, Roots I. Molecular genetics of cancer susceptibility. Pharmacology 2000; 61: 212-27.




2020     |     www.medigraphic.com